Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle
- 1 October 2004
- Vol. 327 (2) , 262-272
- https://doi.org/10.1016/j.virol.2004.07.009
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Recent insights into HIV accessory proteinsCurrent Infectious Disease Reports, 2003
- DNA vaccination of macaques by a full-genome simian/human immunodeficiency virus type 1 plasmid chimera that produces non-infectious virus particlesJournal of General Virology, 2003
- Mutational analysis of two zinc-finger motifs in the nucleocapsid protein of simian immunodeficiency virus mac239Journal of General Virology, 2003
- Human Immunodeficiency Virus Type 1 Env with an Intersubunit Disulfide Bond Engages Coreceptors but Requires Bond Reduction after Engagement To Induce FusionJournal of Virology, 2003
- Replication of lentivirusesFrontiers in Bioscience-Landmark, 2003
- Different Patterns of Immune Responses but Similar Control of a Simian-Human Immunodeficiency Virus 89.6P Mucosal Challenge by Modified Vaccinia Virus Ankara (MVA) and DNA/MVA VaccinesJournal of Virology, 2002
- Critical Role for Env as well as Gag-Pol in Control of a Simian-Human Immunodeficiency Virus 89.6P Challenge by a DNA Prime/Recombinant Modified Vaccinia Virus Ankara VaccineJournal of Virology, 2002
- DNA Vaccination of Macaques by a Full Genome HIV-1 Plasmid Which Produces Noninfectious Virus ParticlesVirology, 2000
- Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation.Proceedings of the National Academy of Sciences, 1995
- Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cellsGene, 1988